SBH
PCVX icon

Segall Bryant & Hamill’s Vaxcyte PCVX Stock Holding History

Segall Bryant & Hamill’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$10.7M Sell
183,935
-9,488
-5% -$515K 0.15% 219
2025
Q4 		$8.92M Buy
193,423
+8,628
+5% +$386K 0.12% 245
2025
Q3 		$6.66M Buy
184,795
+4,556
+3% +$151K 0.09% 287
2025
Q2 		$5.86M Buy
180,239
+30,477
+20% +$999K 0.08% 295
2025
Q1 		$5.66M Sell
149,762
-4,226
-3% -$338K 0.09% 294
2024
Q4 		$12.6M Sell
153,988
-2,068
-1% -$205K 0.17% 181
2024
Q3 		$17.8M Sell
156,056
-6,376
-4% -$575K 0.24% 131
2024
Q2 		$12.3M Buy
162,432
+4,411
+3% +$300K 0.22% 155
2024
Q1 		$10.8M Sell
158,021
-2,260
-1% -$156K 0.2% 173
2023
Q4 		$10.1M Buy
+160,281
New +$8.32M 0.19% 183

Other funds holding PCVX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return